Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin

By Lian Hai   Jin Ningyi   Li Xiao   Mi Zhiqiang   Zhang Jingmin   Sun Lili   Li Xuemei   Zheng Hongling   Li Ping  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 181-192

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS

By                      

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 891-899

Spandidos Publications

Access to resources Recommend Favorite

Activation or frustration of anti-tumor responses by T-cell-based immune modulation

By Toes R.E.M.   Schoenberger S.P.   van der Voort E.I.H.   Kast W.M.   Hoeben R.C.   Melief C.J.M.   Offringa R.  

Seminars in Immunology, Vol. 9, Iss. 5, 1997-10 ,pp. : 323-327

Academic Press

Access to resources Recommend Favorite

Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

By Vicari Alain  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 615-628

Springer Publishing Company

Access to resources Recommend Favorite

Immune aspects of the breast tumor microenvironment

By Chawla Akhil   Alatrash Gheath   Wu Yun   Mittendorf Elizabeth A  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 231-244

Future Medicine

Access to resources Recommend Favorite